ICARES Medicus (ROCO:6612) Tariff Resilience Score: 0/10 (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6612 ICARES Medicus Inc ROCO:6612
86 GF Score
Price NT$71.00
GF Value NT$191.00
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is ICARES Medicus Tariff Resilience Score?

ICARES Medicus has the Tariff Resilience Score of 0, which implies that the company might have .

ICARES Medicus has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes ICARES Medicus might have .

ICARES Medicus  (ROCO:6612) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

ICARES Medicus Tariff Resilience Score Related Terms

ROCO:6612
86GF Score
ICARES Medicus Inc ROCO:6612
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ICARES Medicus (ROCO:6612) Overvalued in 2026?

Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued. The current stock price of NT$71.00 is trading 62.8% below its estimated GF Value™ of NT$191.00. GuruFocus considers ICARES Medicus to be Possible Value Trap.

Key valuation signals for ROCO:6612:

  • Tariff Resilience Score: 0
  • GF Value™: NT$191.00 vs. price of NT$71.00 (62.8% below fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ICARES Medicus Business Description

Address Section 2, Shengyi Road, No. 16, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
86GF Score

Get the complete analysis for ROCO:6612

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.00
Price
NT$191.00
GF Value